Kevin is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

Message Kevin

  • Hidden
  • Hidden
  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please contact us via the website.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • This field is for validation purposes and should be left unchanged.
Back to our people